Literature DB >> 22859424

What do professionals recommend regarding the frequency of self-monitoring of blood glucose?

J Hortensius1, N Kleefstra, S T Houweling, J J van der Bijl, R O B Gans, H J G Bilo.   

Abstract

BACKGROUND: Patients' adherence to guidelines regarding self-monitoring of blood glucose (SMBG) is limited. However, there are no previous reports about the recommendations that are given in clinical practice concerning SMBG. The aim of this study was to investigate what healthcare providers recommend to insulin-treated patients with diabetes regarding frequency and timing of SMBG.
METHODS: In this cross-sectional descriptive study, primary care assistants, diabetes specialised nurses and doctors in the Netherlands were invited via e-mail to complete an internet survey.
RESULTS: A total of 980 (14%) professionals returned the questionnaire. Insulin pump users and patients with type 1 diabetes (T1DM) on 4 injections a day were advised to perform SMBG daily by 96% and 63% of the professionals, respectively. The majority of the professionals advised these patients to perform 3-4 measurements per day. There was less agreement on the timing (pre- and÷or postprandial). Patients with type 2 diabetes (T2DM) on four injections were advised to perform SMBG less frequently. There was a wide variation in recommendations that were given to patients with T2DM on less intensive insulin regimens.
CONCLUSION: This study investigated SMBG from a professional's perspective. A considerable and relevant variation in the recommendations about the number and timing of SMBG was observed. The most striking differences were found in patients with T2DM on less intensive insulin regimes, also with respect to the frequency of SMBG. Well-designed studies are necessary in order to give a more evidence-based advice on the basic frequency and timing of SMBG.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22859424

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  5 in total

Review 1.  Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group.

Authors:  Leszek Czupryniak; László Barkai; Svetlana Bolgarska; Agata Bronisz; Jan Broz; Katarzyna Cypryk; Marek Honka; Andrej Janez; Mladen Krnic; Nebojsa Lalic; Emil Martinka; Dario Rahelic; Gabriela Roman; Tsvetalina Tankova; Tamás Várkonyi; Bogumił Wolnik; Nadia Zherdova
Journal:  Diabetes Technol Ther       Date:  2014-04-09       Impact factor: 6.118

2.  A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial.

Authors:  S Di Molfetta; P Patruno; S Cormio; A Cignarelli; R Paleari; A Mosca; O Lamacchia; S De Cosmo; M Massa; A Natalicchio; S Perrini; L Laviola; F Giorgino
Journal:  J Endocrinol Invest       Date:  2022-04-27       Impact factor: 5.467

3.  Evidence-based clinical use of insulin premixtures.

Authors:  Marcos Antônio Tambascia; Márcia Nery; Jorge Luiz Gross; Mariana Narbot Ermetice; Carolina Piras de Oliveira
Journal:  Diabetol Metab Syndr       Date:  2013-09-06       Impact factor: 3.320

4.  Glycemic control and adherence to basal insulin therapy in Taiwanese patients with type 2 diabetes mellitus.

Authors:  Ming-Nan Chien; Yen-Ling Chen; Yi-Jen Hung; Shu-Yi Wang; Wen-Tsung Lu; Chih-Hung Chen; Ching-Ling Lin; Tze-Pao Huang; Ming-Han Tsai; Wei-Kung Tseng; Ta-Jen Wu; Cheng Ho; Wen-Yu Lin; Bill Chen; Lee-Ming Chuang
Journal:  J Diabetes Investig       Date:  2016-05-30       Impact factor: 4.232

5.  Effects of three frequencies of self-monitored blood glucose on HbA1c and quality of life in patients with type 2 diabetes with once daily insulin and stable control: a randomized trial.

Authors:  Johanna Hortensius; Nanne Kleefstra; Gijs W D Landman; Bas T Houweling; Klaas H Groenier; Jaap J van der Bijl; Henk Bilo
Journal:  BMC Res Notes       Date:  2018-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.